D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

And when a tight group of Texas Tech power brokers saw it last summer, their football and financial instincts kicked in as ...

As a result, the largest names in many style indices, especially on the growth side, make up a higher and higher percentage ...

Mr. Bond to establish and scale Bitfarms North American HPC/AI businessTORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TS ...

UBISOFT ACCELERATES ITS TRANSFORMATION BY LAYING FOUNDATION FOR NEW OPERATING MODEL WITH THE CREATION OF A SUBSIDIARY AND INJECTION OF €1.16BN OF CASH FROM SELECTED INVESTOR TENCENT ...

UBISOFT ACCELERATES ITS TRANSFORMATION BY LAYING FOUNDATION FOR NEW OPERATING MODEL WITH THE CREATION OF A SUBSIDIARY AND INJECTION OF €1.16BN OF CASH FROM SELECTED INVESTOR TENCENT PARIS - March 27 ...

Secretary of State Marco Rubio has appointed an official from Elon Musk’s Department of Government Efficiency to head ...

Seven weeks had passed since he stunned the world by conquering most of Syria in an 11-day blitzkrieg that put an end to the ...

As we mark Women's History Month 2025, TravelPulse is once again taking a moment to acknowledge the substantial contributions ...

EQS Post-admission Duties announcement: BP p.l.c. / Transaction in Own Shares BP p.l.c.: Release of a capital market information 27.03.2025 / 19:10 CET/CEST Dissemination of a Post-admission Duties ...

RBC Capital analyst Matthew Hedberg maintained a Buy rating on SailPoint, Inc. (SAIL – Research Report) yesterday and set a price target of ...

The Capital Market Authority (CMA) released a draft of the "Development of Investor Categories in the Parallel Market" ...